Incidence and risk of hypertension associated with PARP inhibitors in cancer patients: A systematic review and meta-analysis
Số trang: 17
Loại file: pdf
Dung lượng: 2.12 MB
Lượt xem: 9
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
To analyze the incidence and risk of hypertension associated with poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors in cancer patients and provide reference for clinicians.
Nội dung trích xuất từ tài liệu:
Incidence and risk of hypertension associated with PARP inhibitors in cancer patients: A systematic review and meta-analysis
Nội dung trích xuất từ tài liệu:
Incidence and risk of hypertension associated with PARP inhibitors in cancer patients: A systematic review and meta-analysis
Tìm kiếm theo từ khóa liên quan:
BMC Cancer PARP inhibitors Meta-analysis Cancer patients Advanced cancer DNA damage responseGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 141 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 115 0 0 -
12 trang 91 0 0
-
19 trang 74 0 0
-
17 trang 62 0 0
-
9 trang 39 0 0
-
11 trang 37 0 0
-
12 trang 36 0 0